Phospholipase A2 enzymes.
I. Kudo,
M. Murakami
|
9 |
2002 |
9
2002
|
Distinct functions of COX-1 and COX-2.
I. Morita
|
8 |
2002 |
8
2002
|
Cyclooxygenase isozymes and their gene structures and expression.
T. Tanabe,
N. Tohnai
|
8 |
2002 |
8
2002
|
Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.
Mu‐En Lin,
D. Herr,
J. Chun
|
8 |
2010 |
8
2010
|
Prostaglandin catabolizing enzymes.
H. Tai,
C. Ensor,
M. Tong,
Huiping Zhou,
Fengxiang Yan
|
8 |
2002 |
8
2002
|
The cannabinoid receptors.
A. Howlett
|
8 |
2002 |
8
2002
|
Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
C. Serhan,
K. Gotlinger,
Song Hong,
M. Arita
|
8 |
2004 |
8
2004
|
Regulation of inflammation in cancer by eicosanoids.
Emily R. Greene,
Sui Huang,
C. Serhan,
D. Panigrahy
|
8 |
2011 |
8
2011
|
Prostaglandin E synthase.
M. Murakami,
Yoshihito Nakatani,
T. Tanioka,
I. Kudo
|
8 |
2002 |
8
2002
|
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.
C. Hillard
|
7 |
2000 |
7
2000
|
Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
K. Weylandt,
Cheng-Ying Chiu,
Beate Gomolka,
S. Waechter,
B. Wiedenmann
|
7 |
2012 |
7
2012
|
Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.
C. Serhan
|
7 |
2002 |
7
2002
|
Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications.
H. Kuhn,
M. Walther,
R. Kuban
|
7 |
2002 |
7
2002
|
Receptors for acylethanolamides-GPR55 and GPR119.
G. Godlewski,
László Offertáler,
J. Wagner,
G. Kunos
|
7 |
2009 |
7
2009
|
Lysophosphatidic acid synthesis and release.
C. Pagès,
M. Simon,
P. Valet,
J. Saulnier-Blache
|
7 |
2001 |
7
2001
|
